BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 36397369)

  • 21. Bone marrow findings in metastatic melanoma, including role of BRAF immunohistochemistry.
    Corean JLE; George TI; Patel JL; Li KD
    Int J Lab Hematol; 2019 Aug; 41(4):550-560. PubMed ID: 31112348
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunohistochemical staining of bone marrow biopsies for detection of occult metastasis in breast cancer.
    Mathieu MC; Friedman S; Bosq J; Caillou B; Spielmann M; Travagli JP; Contesso G
    Breast Cancer Res Treat; 1990 Jan; 15(1):21-6. PubMed ID: 2328327
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bone marrow involvement in patients with metastatic castration sensitive prostate cancer.
    Shahait M; Abu-Hijlih R; Salamat A; Abou Heidar N; Sharaf B; Abuhijla F; Salah S
    PLoS One; 2022; 17(7):e0270956. PubMed ID: 35862364
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Diagnostic value of bone marrow biopsy for bone marrow metastatic tumor with unknown primary tumor site].
    Wu Y; Yao LQ; Cheng J; Tian H
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 May; 30(5):1069-71. PubMed ID: 20501396
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Comparison of bone marrow biopsy and smear efficacy in patients with multiple myeloma].
    Su JY; Tao Y; Liu YZ; Zhou LY; Yang LP; Liu H; Chang CK
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Dec; 20(6):1389-91. PubMed ID: 23257439
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical and prognostic evaluation of bone marrow infiltration (biopsy versus aspirate) in early chronic lymphocytic leukemia. A single center study.
    Molica S; Tucci L; Levato D; Docimo C
    Haematologica; 1997; 82(3):286-90. PubMed ID: 9234573
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Flow cytometric immunophenotyping is of great value to diagnosis of natural killer cell neoplasms involving bone marrow and peripheral blood.
    Jiang NG; Jin YM; Niu Q; Zeng TT; Su J; Zhu HL
    Ann Hematol; 2013 Jan; 92(1):89-96. PubMed ID: 22992980
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical characteristics and prognosis of high-risk neuroblastoma with bone marrow metastasis in children].
    Fan HJ; Huang C; Su Y; Wang XD; Zhou YC; Duan C; Zhao W; Zhao Q; Jin M; Ma XL
    Zhonghua Er Ke Za Zhi; 2019 Nov; 57(11):863-869. PubMed ID: 31665841
    [No Abstract]   [Full Text] [Related]  

  • 29. [Analysis of Clinical and Hematologic Features in 22 Patients with Metastatic Carcinoma of Bone Marrow].
    Sun H; Wang GJ; Liu LX; Sun L; Zou DB; Liu SJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2001 Dec; 9(4):307-309. PubMed ID: 12578568
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Can flow cytometry of bone marrow aspirate predict outcome of patients with diffuse large B cell lymphoma? A retrospective single centre study.
    Wolach O; Fraser A; Luchiansky M; Shapiro C; Radnay J; Shpilberg O; Lishner M; Lahav M
    Hematol Oncol; 2015 Mar; 33(1):42-7. PubMed ID: 24470400
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Value of imprint preparations of bone marrow biopsies in hematologic diagnosis.
    James LP; Stass SA; Schumacher HR
    Cancer; 1980 Jul; 46(1):173-7. PubMed ID: 6893011
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In newly diagnosed diffuse large B-cell lymphoma, determination of bone marrow involvement with 18F-FDG PET/CT provides better diagnostic performance and prognostic stratification than does biopsy.
    Berthet L; Cochet A; Kanoun S; Berriolo-Riedinger A; Humbert O; Toubeau M; Dygai-Cochet I; Legouge C; Casasnovas O; Brunotte F
    J Nucl Med; 2013 Aug; 54(8):1244-50. PubMed ID: 23674577
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metastatic bone marrow tumours: a report of six cases and review of the literature.
    Sar R; Aydogdu I; Ozen S; Sevinc A; Buyukberber S
    Haematologia (Budap); 2001; 31(3):215-23. PubMed ID: 11855783
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metastatic carcinoma in histologic sections of aspirated bone marrow: a comparative autopsy study.
    Suprun H; Rywlin AM
    South Med J; 1976 Apr; 69(4):438-9. PubMed ID: 1265504
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic value of hematogenous dissemination and biological profile of the tumor in early breast cancer patients: a prospective observational study.
    Solá M; Margelí M; Castellá E; Julian JF; Rull M; Gubern JM; Mariscal A; Barnadas A; Fraile M
    BMC Cancer; 2011 Jun; 11():252. PubMed ID: 21679400
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bone marrow involvement by metastatic solid tumors.
    Sharma S; Murari M
    Indian J Pathol Microbiol; 2003 Jul; 46(3):382-4. PubMed ID: 15025279
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lymphoid aggregates in bone marrow trephines: new approaches to a continuing problem.
    Crocker J
    J Pathol; 1996 Apr; 178(4):367-8. PubMed ID: 8691312
    [No Abstract]   [Full Text] [Related]  

  • 38. Bone marrow metastasis by solid tumors--probable hematological indicators and comparison of bone marrow aspirate, touch imprint and trephine biopsy.
    Chandra S; Chandra H; Saini S
    Hematology; 2010 Oct; 15(5):368-72. PubMed ID: 20863433
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bone marrow examination: for metastatic tumor: aspirate and biopsy.
    Singh G; Krause JR; Breitfeld V
    Cancer; 1977 Nov; 40(5):2317-21. PubMed ID: 922673
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of wide-spectrum cytokeratin staining of the bone marrow cores in patients with ductal carcinoma of the breast.
    Dunphy CH
    Mod Pathol; 1996 Oct; 9(10):955-8. PubMed ID: 9005447
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.